Edwards Lifesciences Corp
NYSE:EW
Wall Street
Price Targets
EW Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EW is 96.21 USD with a low forecast of 72.72 USD and a high forecast of 110.25 USD.
EW Last Price Targets
Edwards Lifesciences Corp
The latest public price target was made on Apr 15, 2024 by Shagun Singh from RBC Capital , who expects EW stock to rise by 14% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Shagun Singh
RBC Capital
|
101
USD
Upside 14% |
1 week ago
Apr 15, 2024
|
Edwards Lifesciences price target raised to $101 from $95 at RBC Capital
TheFly
|
Anthony Petrone
Mizuho Securities
|
105
USD
Upside 18% |
2 weeks ago
Apr 11, 2024
|
Edwards Lifesciences price target raised to $105 from $95 at Mizuho
TheFly
|
Suraj Kalia
Oppenheimer
|
100
USD
Upside 13% |
1 month ago
Mar 18, 2024
|
Edwards Lifesciences (EW) PT Raised to $100 at Oppenheimer
StreetInsider
|
Unknown Analyst
Canaccord Genuity
|
76
USD
Downside 14% |
1 year ago
Feb 1, 2023
|
Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $76
Benzinga
|
Unknown Analyst
Truist Financial
|
86
USD
Downside 3% |
1 year ago
Feb 1, 2023
|
Truist Securities Maintains Buy on Edwards Lifesciences, Raises Price Target to $86
Benzinga
|
Operating Income
Forecast
Operating Income Estimate
Edwards Lifesciences Corp
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's operating income is 13%. The projected CAGR for the next 3 years is 12%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EW's stock price target?
Price Target
96.21
USD
According to Wall Street analysts, the average 1-year price target for EW is 96.21 USD with a low forecast of 72.72 USD and a high forecast of 110.25 USD.
What is Edwards Lifesciences Corp's Revenue forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's revenue is 12%. The projected CAGR for the next 3 years is 10%.
What is Edwards Lifesciences Corp's Operating Income forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's operating income is 13%. The projected CAGR for the next 3 years is 12%.
What is Edwards Lifesciences Corp's Net Income forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's net income is 14%. The projected CAGR for the next 3 years is 15%.